Abbott Gets TriLipix Approval, Ensuring Lipid Lowering Franchise Beyond TriCor
This article was originally published in The Pink Sheet Daily
Executive Summary
Approval bodes positively for Abbott/AstraZeneca’s joint development of a TriLipix/Crestor combination.